Severe respiratory syncytial virus disease in preterm infants: a case of innate immaturity

Jeremy Anderson1, Lien Anh Ha Do1,2, Danielle Wurzel1,2,3

  • 1Infection and Immunity, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.

Thorax
|February 12, 2021
PubMed

Insights

Preterm infants face higher risks of severe respiratory syncytial virus (RSV) infection due to immature innate immunity. Understanding these immune differences is key to developing new treatments for vulnerable infants.

Area of Science:

  • Immunology
  • Pediatrics
  • Virology

Background:

  • Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infections (LRTI) in young children.
  • Severe RSV disease can lead to chronic respiratory issues like asthma and recurrent wheezing.
  • Premature gestation is a significant risk factor for severe RSV, linked to an underdeveloped innate immune system.

Purpose of the Study:

  • To compare innate immune responses between preterm and term infants.
  • To elucidate the reasons for increased susceptibility to severe RSV in preterm infants.
  • To identify early life immune biomarkers for severe RSV disease risk.

Main Methods:

  • Comparative analysis of innate immunity aspects in preterm versus term infants.
  • Review of existing literature on RSV pathogenesis and infant immune development.
  • Exploration of potential immune biomarkers for disease severity.

Main Results:

  • Preterm infants possess an immature innate immune system, compromising pathogen defense.
  • This immune immaturity increases vulnerability to severe RSV infection.
  • Key differences in innate immunity between preterm and term infants contribute to disease severity.

Conclusions:

  • Understanding innate immunity disparities is crucial for addressing severe RSV in preterm infants.
  • Identifying specific immune biomarkers can guide targeted interventions.
  • Reducing the burden of RSV disease in this high-risk population is a critical goal.

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
730
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
562
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
517
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
293
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.8K
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.1K